Drug · DIN 02238984
URSO
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since December 16, 2022; first marketed November 8, 1998.
- Drug Identification Number (DIN)
- 02238984
- Company (DIN owner)
- Aptalis Pharma Canada UlcMarkham, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Ursodeoxycholic acid A05AA02
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| URSODIOL | 250 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 29, 2011: NOC 12808New Drug Submission (NDS) · Manufacturer Name Change
- November 1, 1998: NOC 3153Supplement to a New Drug Submission (SNDS) · Provides for a new dosage form, change in product name from ursofalk to urso